Papers matching “major adverse cardiovascular events” 385
Not finding it? Sign in to also search OpenAlex live.
-
Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease
Philippe Gabríel Steg, Shaun G. Goodman, J. Wouter Jukema, Pieter Martens, Andreas Zirlik, Deepak L. Bhatt, +9 more
4citations -
FC007: The Impact of Sex on the Risk Of Major Adverse Cardiovascular Events in Older Adults with Advanced Chronic Kidney Disease: Results from the Equal Study2022 Nephrology Dialysis Transplantation conference-abstract Medicine Chronic Kidney Disease and Diabetes
Megan E Astley, Friedo Wilhelm Dekker, Marie Evans, Fergus John Caskey, Claudia Torino, Gaetana Porto, +5 more
0citations -
Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy2026 European Heart Journal article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access
Koen H.M. Prange, Gemma Bel-Bordes, MAC Depuydt, Panos Barlampas, Moritz Reif, Max L.B. Grönloh, +24 more
11citations -
Comparison of High‐Sensitivity Troponin T Versus N‐Terminal Pro‐B‐Type Natriuretic Peptide for Prediction of Major Adverse Cardiovascular Events After Noncardiac Surgery2026 Journal of the American Heart Association article Medicine Cardiac, Anesthesia and Surgical Outcomes Open access
Anna Kirkopoulos, Jan Larmann, René M’Pembele, Vlad‐Ionut Bucur‐Cristescu, Theresa Tenge, Judith A. R. van Waes, +6 more
0citations -
Whole heart atherosclerosis volume and risk for major adverse cardiovascular events across the clinical likelihood for obstructive CAD; the CONFIRM2 study2026 American Journal of Preventive Cardiology article Medicine Cardiac Imaging and Diagnostics Open access
Alexander R. van Rosendael, Rine Nakanishi, Jeroen Joost Bax, Gianluca Pontone, Saima Mushtaq, Ronny R. Buechel, +51 more
1citations -
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
José Tuñón, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, +11 more
76citations -
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes2022 Journal of clinical lipidology article Medicine Lipoproteins and Cardiovascular Health Open access
Patrick M. Moriarty, Philippe Gabríel Steg, Jennifer McGinniss, Andreas Michael Zeiher, Harvey Douglas White, Garen Z. Manvelian, +12 more
5citations -
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation2023 International Journal of Molecular Sciences article Medicine Atrial Fibrillation Management and Outcomes Open access cited by 1 patent
Stephan Nopp, M. Leontien van der Bent, Daniel Kraemmer, Oliver Königsbrügge, Johann Wojta, Ingrid Pabinger, +2 more
5citations -
Short‐Term Major Adverse Cardiovascular Events Following Postpartum Haemorrhage: A Cohort Study (The MACEPH Study)2026 BJOG An International Journal of Obstetrics & Gynaecology article Medicine Maternal and fetal healthcare Open access
Isabelle Malhamé, Robin Campen, Mara Bensson, Clarissa Andre, Sally Twin, Ambreen Syeda, +15 more
0citations -
Evaluation of pulse wave velocity for predicting major adverse cardiovascular events in post-infarcted patients; comparison of oscillometric and MRI methods2021 Reviews in Cardiovascular Medicine article Medicine Cardiovascular Health and Disease Prevention Open access
Zsófia Meiszterics, Tamás Símor, Rob J. van der Geest, Nelli Farkas, Balázs Gaszner
3citations -
P520 Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme2023 Journal of Crohn s and Colitis article Medicine Rheumatoid Arthritis Research and Therapies Open access
Janneke van der Woude, S Schreiber, Laurent Peyrin‐Biroulet, Zoltán Szekanecz, E.H. Choy, Pieter-Jan Stiers, +4 more
2citations -
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry2023 Journal of Thrombosis and Thrombolysis article Medicine Atrial Fibrillation Management and Outcomes Open access
Wern Yew Ding, Ameenathul M. Fawzy, Giulio Francesco Romiti, Marco Proietti, Daniele Pastori, Menno Volkert Huisman, +86 more
7citations -
Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome
J. Wouter Jukema, Nicolaas J.M. van Neer, Michael J. Szarek, Christa M. Cobbaert, Vera Bittner, Markus Schwertfeger, +8 more
2citations -
Independent and cumulative prognostic information of C-reactive protein and interleukin-6 to predict major adverse cardiovascular events and death in post acute coronary syndrome patients
J W Jukema, Nicolaas J.M. van Neer, MICHAEL SZAREK, C. Cobbaert, Vera Bittner, Markus Schwertfeger, +8 more
0citations -
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA–AF registry2024 Internal and Emergency Medicine article Medicine Atrial Fibrillation Management and Outcomes Open access
Steven Ho Man Lam, Giulio Francesco Romiti, Brian Olshansky, Tze‐Fan Chao, Menno Volkert Huisman, Gregory Y.H. Lip
4citations -
Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome2026 American Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Gregory G. Schwartz, Michael J. Szarek, Vera Bittner, Deepak L. Bhatt, Rafael Diaz, Shaun G. Goodman, +8 more
0citations -
OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
R. Aymon, Denis Mongin, Sytske Anne Bergstra, D. Choquette, Cătălin Codreanu, René Cordtz, +24 more
6citations -
Progression of whole-heart Atherosclerosis by coronary CT and major adverse cardiovascular events2021 Journal of cardiovascular computed tomography article Medicine Cardiac Imaging and Diagnostics Open access
Alexander R. van Rosendael, Fay Yu-Huei Lin, Inge J. van den Hoogen, Xiaoyue Ma, Umberto Gianni, Omar Al Hussein Alawamlh, +32 more
46citations -
Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)2021 Journal of Clinical Medicine article Pharmacology, Toxicology and Pharmaceutics Pharmacovigilance and Adverse Drug Reactions Open access
Annika Vestergaard Kvist, Junaid Faruque, Enriqueta Vallejo‐Yagüe, Stefan Weiler, Elizabeth Martha Winter, Andrea Michelle Burden
88citations -
Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry2023 Journal of Thrombosis and Thrombolysis erratum Medicine Atrial Fibrillation Management and Outcomes Open access
Wern Yew Ding, Ameenathul M. Fawzy, Giulio Francesco Romiti, Marco Proietti, Daniele Pastori, Menno Volkert Huisman, +1 more
1citations